Nasoxylin (Oxymetazoline Hydrochloride)

Oxymetazoline hydrochloride is a selective alpha‑adrenergic agonist. When applied to the nasal mucosa, it stimulates alpha receptors on blood‑vessel smooth muscle, causing vasoconstriction. This reduces mucosal edema and opens the nasal airway, providing rapid decongestion.

The appropriate dose of Nasoxylin is determined by a qualified healthcare professional based on the patient’s age, condition, and response. Users should follow the prescriber’s instructions and not exceed the recommended duration of use.

Safety data for oxymetazoline during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using Nasoxylin to weigh potential benefits against risks.

To order Nasoxylin, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nasoxylin’s active ingredient, oxymetazoline, provides rapid, long‑lasting decongestion compared with some short‑acting agents like phenylephrine. However, all topical decongestants share a risk of rebound congestion if used beyond the recommended 3‑5‑day limit.

Store Nasoxylin at ambient temperature, below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight, and extreme heat. Ensure the cap is tightly closed to maintain product integrity.

Nasoxylin is administered intranasally. The user sprays the recommended number of sprays into each nostril as directed by a healthcare professional, typically while the head is upright, and avoids blowing the nose immediately after application.

Serious risks include rebound nasal congestion with prolonged use, significant elevation of blood pressure, tachycardia, and rare allergic reactions such as rash or angioedema. Patients should discontinue use and seek medical attention if these symptoms occur.

Nasoxylin should not be used by individuals with known hypersensitivity to oxymetazoline or any formulation components, those taking monoamine oxidase inhibitors, patients with severe hypertension, or children under six years of age unless specifically advised by a physician.